TNFRSF4 and chronic myelogenous leukemia, BCR-ABL1 positive: Stimulation of Tnfrsf4-signaling did not deplete Tregs but reduced the capacity of Tregs to protect LSCs from granzyme-mediated CD8+ CTL- killing in a murine CML model.